We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

71 hedge funds and large institutions have $8.86M invested in Ampio Pharmaceuticals Inc. in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 21 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 74 → 71 (-3)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

33% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 21

44% less capital invested

Capital invested by funds: $15.8M → $8.86M (-$6.9M)

69% less call options, than puts

Call options by funds: $52K | Put options by funds: $166K

Holders
71
Holders Change
-3
Holders Change %
-4.05%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
14
Reduced
21
Closed
8
Calls
$52K
Puts
$166K
Net Calls
-$114K
Net Calls Change
-$251K

Top Buyers

Rank Fund Capital Flow
1
NFG
Noven Financial Group
Colorado
+$236K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$208K
3
Renaissance Technologies
Renaissance Technologies
New York
+$162K
4
BFA
BlackRock Fund Advisors
California
+$89.2K
5
SG Americas Securities
SG Americas Securities
New York
+$65.1K

Top Sellers

Rank Fund Capital Flow
1
KCM
Knoll Capital Management
Florida
-$467K
2
BCM
Bridgeway Capital Management
Texas
-$255K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$96K
4
Wolverine Trading
Wolverine Trading
Illinois
-$55K
5
Citadel Advisors
Citadel Advisors
Florida
-$48.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$33K +$1.12K +4 +3%
UBS Group
27
UBS Group
Switzerland
$29K +$9.25K +33 +35%
Brown Advisory
28
Brown Advisory
Maryland
$25K +$15.4K +55 +98%
NFA
29
Nationwide Fund Advisors
Ohio
$20K – – –
Wells Fargo
30
Wells Fargo
California
$19K -$2.52K -9 -9%
AG
31
Advisor Group
Arizona
$19K – – –
AIG
32
American International Group
New York
$18.7K – – –
Wolverine Trading
33
Wolverine Trading
Illinois
$18K -$55K -196 -71%
CS
34
Credit Suisse
Switzerland
$18K -$2.8K -10 -11%
GC
35
Guggenheim Capital
Illinois
$18K +$7.57K +27 +50%
BA
36
BlackRock Advisors
Delaware
$16K -$841 -3 -4%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$15K – – –
OC
38
Oppenheimer & Co
New York
$15K – – –
NFG
39
Next Financial Group
Texas
$15K +$18.8K +67 New
OWP
40
Obermeyer Wealth Partners
Colorado
$14K – – –
JWA
41
JFS Wealth Advisors
Pennsylvania
$13K – – –
Morgan Stanley
42
Morgan Stanley
New York
$12K -$14.3K -51 -49%
Bank of America
43
Bank of America
North Carolina
$12K +$14.9K +53 +1,325%
ARTA
44
A.R.T. Advisors
New York
$11K -$12.3K -44 -46%
CC
45
Courier Capital
New York
$11K – – –
PNC Financial Services Group
46
PNC Financial Services Group
Pennsylvania
$10K – – –
PAG
47
Private Advisor Group
New Jersey
$10K +$11.8K +42 New
CG
48
Cutler Group
California
$9K -$4.21K -15 -27%
Goldman Sachs
49
Goldman Sachs
New York
$9K +$1.68K +6 +17%
RJA
50
Raymond James & Associates
Florida
$9K +$11.5K +41 New
1
2
3 4

AMPE Hedge Fund Activity: Q3 2016 in Review

71 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2016, worth a combined $8.86M — down 44% from $15.8M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of AMPE and 6 opened new positions — a net loss of 2 holders — while 21 trimmed existing stakes and 14 added.

The largest buyer was Noven Financial Group, adding an estimated $236K. The largest seller was Knoll Capital Management, cutting an estimated $467K.

  • 71 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2016, down from 74 in Q2 2016.
  • Funds reported $8.86M of Ampio Pharmaceuticals Inc. stock for Q3 2016, down 44% quarter-over-quarter.
  • 6 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2016 and 8 closed out, a net change of -2 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q3 2016 was Noven Financial Group, an estimated $236K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q3 2016 was Knoll Capital Management, an estimated $467K sold.

Based on aggregated 13F filings for Q3 2016.